-
Topics
- All Topics
- Self Care
- Blood & Skin
- Cancer
- Cardiovascular & Respiratory
-
Children & Family
- Child Emotional Wellbeing & Mental Health
- Children, Young People & Family
- Domestic Violence & Abuse
- Female Genital Mutilation
- Gender Identity Adults
- Homelessness
- Learning Disabilities
- Migrant Health
- Neurodiversity
- Safeguarding Adults
- Safeguarding Children
- Sexual Health
- Social Prescribing
- Speech & Language Therapy
- Diabetes & Endocrine
- Diagnostics & Investigations
- Frailty & Complex Care
- Gastroenterology, Colorectal, Renal & Urology
- Head, Neck & Eyes
- Infectious Diseases
- Mental Health
- MSK
- Neurology & Neurosurgery
- Nutrition & Weight Management
- Obstetrics & Gynaecology
- Social Care & Safeguarding
- Urgent & Emergency
- Clinical Pathways
-
Medicines
- Controlled Drugs
- Electronic Prescription Service
- Infections & Antimicrobials
- Medicines Compliance
- Medicines Optimisation Prescribing Policies
- Medicines Optimisation Team
- Medicines Supply Issues
- Patient Group Directions
- Prescribing Guidelines
- Prescribing Quality Scheme
- Prescribing Recommendations
- Self-Care Medicines Scheme
- Shared Care
- Fact Sheets
-
Practice Management
- Cancer Care Resources NCL
- Cancer Care Resources NWL
- Deadlines
- Enhanced Services
- GP Feedback and Alert System
- General Practice Change Management Support
- General Practice Staff Survey
- Greener NCL: Sustainable General Practice
- Hospital Bypass Contacts
- Immunisations & Vaccinations
- Individual Funding Requests
- Practice Vacancies
- Primary Care/Secondary Care Interface
- Referral Support
- Research Opportunities
- Support for Staff
- Education
- Digital
Neuro-oncology Service: Charing Cross Hospital
BrentEalingHammersmith & FulhamHarrowHillingdonHounslowKensington & ChelseaWestminsterNeurology services provide diagnostic and management support for a range of neurological conditions.
Eligibility Criteria
Inclusions
New Cranial/Spinal tumours confirmed on imaging including benign and primary malignant (eg. meningioma, glioma, astrocytoma, oligodendroglioma, ependymoma) and metastatic.
Known Cranial/Spinal tumours that have been lost to follow up, including benign and primary malignant (eg. meningioma, glioma, astrocytoma, oligodendroglioma, ependymoma) and metastatic.
Confirmed cranial/spinal tumours who have moved into our locality and require transfer of care, including benign and primary malignant (eg. meningioma, glioma, astrocytoma, oligodendroglioma, ependymoma) and metastatic, following request from the patient.
Exclusions
Suspected Cranial/Spinal tumours who have not undergone imaging – these should be referred to the Brain CNS 2WW service via E-RS.
Acute presentations – these patients should be directed to their local Emergency Department.
Skull base and pituitary lesions – these cases should be referred via the relevant pathway (skull base or pituitary) on E-RS.
Patients aged under 16 years.
How to Refer
Letter
Referral methods: Email
Cranial enquiries email: imperial.neurosurgeryenquiries@nhs.net
Spinal enquiries email: imperial.neurospineenquiries@nhs.net